Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)

This study has been completed.
Information provided by (Responsible Party):
W. Dewilde, R&D Cardiologie Identifier:
First received: October 8, 2008
Last updated: January 12, 2013
Last verified: January 2013